Invesco’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-18,444
Closed -$974K 3869
2020
Q3
$974K Sell
18,444
-4,602
-20% -$284K ﹤0.01% 2831
2020
Q2
$1.41M Buy
23,046
+102
+0.4% +$5.9K ﹤0.01% 2635
2020
Q1
$1.3M Buy
22,944
+1,654
+8% +$94.3K ﹤0.01% 2617
2019
Q4
$1.21M Sell
21,290
-88
-0.4% -$4.67K ﹤0.01% 2900
2019
Q3
$1.15M Buy
21,378
+4,162
+24% +$242K ﹤0.01% 2925
2019
Q2
$1.03M Sell
17,216
-5,811
-25% -$366K ﹤0.01% 3061
2019
Q1
$1.44M Sell
23,027
-839
-4% -$55.5K ﹤0.01% 2816
2018
Q4
$1.45M Sell
23,866
-1,876
-7% -$112K ﹤0.01% 2754
2018
Q3
$1.51M Buy
25,742
+2,207
+9% +$113K ﹤0.01% 2943
2018
Q2
$1.05M Buy
23,535
+2,320
+11% +$99.8K ﹤0.01% 3105
2018
Q1
$940K Sell
21,215
-19,193
-47% -$806K ﹤0.01% 3054
2017
Q4
$1.75M Sell
40,408
-12,282
-23% -$552K ﹤0.01% 2686
2017
Q3
$2.45M Sell
52,690
-248
-0.5% -$11.9K ﹤0.01% 2425
2017
Q2
$2.62M Sell
52,938
-2,459
-4% -$129K ﹤0.01% 2355
2017
Q1
$3.04M Sell
55,397
-1,781
-3% -$94.3K ﹤0.01% 2299
2016
Q4
$3.19M Sell
57,178
-1,698
-3% -$81.6K ﹤0.01% 2270
2016
Q3
$2.69M Buy
58,876
+7,441
+14% +$299K ﹤0.01% 2364
2016
Q2
$2.05M Buy
51,435
+7,205
+16% +$264K ﹤0.01% 2464
2016
Q1
$1.54M Sell
44,230
-33,074
-43% -$1.21M ﹤0.01% 2636
2015
Q4
$3.32M Buy
77,304
+5,806
+8% +$291K ﹤0.01% 2200
2015
Q3
$3.11M Buy
71,498
+6,529
+10% +$352K ﹤0.01% 2196
2015
Q2
$3.35M Buy
64,969
+18,819
+41% +$802K ﹤0.01% 2278
2015
Q1
$1.81M Buy
46,150
+11,760
+34% +$461K ﹤0.01% 2669
2014
Q4
$1.33M Buy
34,390
+2,090
+6% +$79.7K ﹤0.01% 2777
2014
Q3
$1.14M Buy
32,300
+24,950
+339% +$733K ﹤0.01% 2889
2014
Q2
$199K Buy
+7,350
New +$191K ﹤0.01% 3706

Other funds holding BSTC

Invesco's BSTC Position: Q4 2020 in Review

Invesco sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 18,444 shares — an estimated $974K sold.

Invesco first reported a position in BSTC in Q2 2014 and held it in 26 quarters. The position peaked at $3.35M in Q2 2015. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • Invesco reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • Invesco sold 18,444 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $974K.
  • Invesco first reported a position in BioSpecifics Technologies Corp. in Q2 2014 and held it in 26 quarters.
  • Invesco's BioSpecifics Technologies Corp. position peaked at $3.35M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Invesco's 13F filing for Q4 2020, filed 16 Feb 2021.